HEADER    PROTEIN FIBRIL                          19-JUL-17   5WIQ              
TITLE     CRYSTAL STRUCTURE OF THE SEGMENT, GFNGGFG, FROM THE LOW COMPLEXITY    
TITLE    2 DOMAIN OF TDP-43, RESIDUES 396-402                                   
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: TAR DNA-BINDING PROTEIN 43;                                
COMPND   3 CHAIN: A, B;                                                         
COMPND   4 FRAGMENT: UNP RESIDUES 396-402;                                      
COMPND   5 SYNONYM: TDP-43;                                                     
COMPND   6 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 SYNTHETIC: YES;                                                      
SOURCE   3 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   4 ORGANISM_COMMON: HUMAN;                                              
SOURCE   5 ORGANISM_TAXID: 9606;                                                
SOURCE   6 OTHER_DETAILS: SYNTHETIC PEPTIDE GFNGGFG CORRESPONDING TOSEGMENT     
SOURCE   7 396-402 OF TDP-43                                                    
KEYWDS    AMYLOID, LARKS, TDP-43, PROTEIN FIBRIL                                
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    E.L.GUENTHER,M.R.SAWAYA,D.S.EISENBERG                                 
REVDAT   6   18-DEC-19 5WIQ    1       REMARK                                   
REVDAT   5   20-FEB-19 5WIQ    1       REMARK                                   
REVDAT   4   20-JUN-18 5WIQ    1       JRNL                                     
REVDAT   3   06-JUN-18 5WIQ    1       JRNL                                     
REVDAT   2   30-MAY-18 5WIQ    1       JRNL                                     
REVDAT   1   18-APR-18 5WIQ    0                                                
JRNL        AUTH   E.L.GUENTHER,Q.CAO,H.TRINH,J.LU,M.R.SAWAYA,D.CASCIO,         
JRNL        AUTH 2 D.R.BOYER,J.A.RODRIGUEZ,M.P.HUGHES,D.S.EISENBERG             
JRNL        TITL   ATOMIC STRUCTURES OF TDP-43 LCD SEGMENTS AND INSIGHTS INTO   
JRNL        TITL 2 REVERSIBLE OR PATHOGENIC AGGREGATION.                        
JRNL        REF    NAT. STRUCT. MOL. BIOL.       V.  25   463 2018              
JRNL        REFN                   ESSN 1545-9985                               
JRNL        PMID   29786080                                                     
JRNL        DOI    10.1038/S41594-018-0064-2                                    
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.25 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : PHENIX 1.11.1_2575                                   
REMARK   3   AUTHORS     : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN            
REMARK   3               : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,           
REMARK   3               : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,            
REMARK   3               : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,              
REMARK   3               : REETAL PAI,RANDY READ,JANE RICHARDSON,               
REMARK   3               : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,           
REMARK   3               : NICHOLAS SAUTER,JACOB SMITH,LAURENT                  
REMARK   3               : STORONI,TOM TERWILLIGER,PETER ZWART                  
REMARK   3                                                                      
REMARK   3    REFINEMENT TARGET : NULL                                          
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.25                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 22.53                          
REMARK   3   MIN(FOBS/SIGMA_FOBS)              : 2.050                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 92.9                           
REMARK   3   NUMBER OF REFLECTIONS             : 1796                           
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.153                           
REMARK   3   R VALUE            (WORKING SET) : 0.152                           
REMARK   3   FREE R VALUE                     : 0.168                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 10.020                          
REMARK   3   FREE R VALUE TEST SET COUNT      : 180                             
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (IN BINS).                           
REMARK   3   BIN  RESOLUTION RANGE  COMPL.    NWORK NFREE   RWORK  RFREE        
REMARK   3     1 22.5336 -  1.2424    0.93     1616   180  0.1516 0.1678        
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELLING.                                             
REMARK   3   METHOD USED        : NULL                                          
REMARK   3   SOLVENT RADIUS     : 1.11                                          
REMARK   3   SHRINKAGE RADIUS   : 0.90                                          
REMARK   3   K_SOL              : NULL                                          
REMARK   3   B_SOL              : NULL                                          
REMARK   3                                                                      
REMARK   3  ERROR ESTIMATES.                                                    
REMARK   3   COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED)     : 0.000            
REMARK   3   PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 14.980           
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 2.51                           
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 3.51                           
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : NULL                                                 
REMARK   3    B22 (A**2) : NULL                                                 
REMARK   3    B33 (A**2) : NULL                                                 
REMARK   3    B12 (A**2) : NULL                                                 
REMARK   3    B13 (A**2) : NULL                                                 
REMARK   3    B23 (A**2) : NULL                                                 
REMARK   3                                                                      
REMARK   3  TWINNING INFORMATION.                                               
REMARK   3   FRACTION: NULL                                                     
REMARK   3   OPERATOR: NULL                                                     
REMARK   3                                                                      
REMARK   3  DEVIATIONS FROM IDEAL VALUES.                                       
REMARK   3                 RMSD          COUNT                                  
REMARK   3   BOND      :  0.005             96                                  
REMARK   3   ANGLE     :  0.692            124                                  
REMARK   3   CHIRALITY :  0.128              6                                  
REMARK   3   PLANARITY :  0.002             20                                  
REMARK   3   DIHEDRAL  :  7.493             26                                  
REMARK   3                                                                      
REMARK   3  TLS DETAILS                                                         
REMARK   3   NUMBER OF TLS GROUPS  : 1                                          
REMARK   3   TLS GROUP : 1                                                      
REMARK   3    SELECTION: ALL                                                    
REMARK   3    ORIGIN FOR THE GROUP (A):  -0.2349  -1.8711 -12.5061              
REMARK   3    T TENSOR                                                          
REMARK   3      T11:   0.0163 T22:   0.0126                                     
REMARK   3      T33:   0.0175 T12:   0.0038                                     
REMARK   3      T13:  -0.0040 T23:   0.0042                                     
REMARK   3    L TENSOR                                                          
REMARK   3      L11:   0.5457 L22:   0.8184                                     
REMARK   3      L33:   0.7135 L12:   0.0629                                     
REMARK   3      L13:   0.1837 L23:   0.3668                                     
REMARK   3    S TENSOR                                                          
REMARK   3      S11:   0.0173 S12:   0.0030 S13:  -0.0104                       
REMARK   3      S21:   0.0076 S22:   0.0093 S23:  -0.0112                       
REMARK   3      S31:   0.0267 S32:   0.0065 S33:  -0.0127                       
REMARK   3                                                                      
REMARK   3  NCS DETAILS                                                         
REMARK   3   NUMBER OF NCS GROUPS : NULL                                        
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 5WIQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JUL-17.                  
REMARK 100 THE DEPOSITION ID IS D_1000229099.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 14-JUN-14                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : 4.5                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : APS                                
REMARK 200  BEAMLINE                       : 24-ID-E                            
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.9791                             
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 315                   
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 1802                               
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.250                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 100.000                            
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 94.4                               
REMARK 200  DATA REDUNDANCY                : 4.100                              
REMARK 200  R MERGE                    (I) : 0.16100                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 5.0000                             
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.25                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.29                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 95.4                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 1.80                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.40600                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : NULL                               
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: PHASER                                                
REMARK 200 STARTING MODEL: 5WDB                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 9.58                                      
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.36                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM SODIUM ACETATE PH 4.5, 800MM       
REMARK 280  SODIUM PHOSPHATE MONOBASIC, 1200MM POTASSIUM PHOSPHATE DIBASIC,     
REMARK 280  VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K                     
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1                              
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DECAMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   2  1.000000  0.000000  0.000000       -9.62000            
REMARK 350   BIOMT2   2  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   2  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   3  1.000000  0.000000  0.000000       -4.81000            
REMARK 350   BIOMT2   3  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   3  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   4  1.000000  0.000000  0.000000        4.81000            
REMARK 350   BIOMT2   4  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   4  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   5  1.000000  0.000000  0.000000        9.62000            
REMARK 350   BIOMT2   5  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   5  0.000000  0.000000  1.000000        0.00000            
DBREF  5WIQ A  396   402  UNP    Q13148   TADBP_HUMAN    396    402             
DBREF  5WIQ B  396   402  UNP    Q13148   TADBP_HUMAN    396    402             
SEQRES   1 A    7  GLY PHE ASN GLY GLY PHE GLY                                  
SEQRES   1 B    7  GLY PHE ASN GLY GLY PHE GLY                                  
FORMUL   3  HOH   *8(H2 O)                                                      
CRYST1    4.810   16.439   22.672  90.63  96.37  91.26 P 1           2          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.207900  0.004584  0.023281        0.00000                         
SCALE2      0.000000  0.060846  0.000824        0.00000                         
SCALE3      0.000000  0.000000  0.044386        0.00000                         
ATOM      1  N   GLY A 396       0.660   0.002  -1.652  1.00  3.97           N  
ANISOU    1  N   GLY A 396      629    503    378     21    -69     25       N  
ATOM      2  CA  GLY A 396      -0.167   0.770  -2.567  1.00  3.76           C  
ANISOU    2  CA  GLY A 396      569    481    378     17    -40     18       C  
ATOM      3  C   GLY A 396       0.487   0.934  -3.929  1.00  2.89           C  
ANISOU    3  C   GLY A 396      432    361    307     28    -49     17       C  
ATOM      4  O   GLY A 396       1.708   0.849  -4.051  1.00  4.83           O  
ANISOU    4  O   GLY A 396      673    601    563     38    -73     11       O  
ATOM      5  N   PHE A 397      -0.332   1.157  -4.955  1.00  3.89           N  
ANISOU    5  N   PHE A 397      539    487    452     25    -31     20       N  
ATOM      6  CA  PHE A 397       0.125   1.346  -6.326  1.00  4.40           C  
ANISOU    6  CA  PHE A 397      584    543    543     31    -34     21       C  
ATOM      7  C   PHE A 397      -0.433   2.667  -6.829  1.00  4.74           C  
ANISOU    7  C   PHE A 397      614    585    603     33    -21     13       C  
ATOM      8  O   PHE A 397      -1.630   2.936  -6.671  1.00  3.85           O  
ANISOU    8  O   PHE A 397      497    478    489     32     -8     10       O  
ATOM      9  CB  PHE A 397      -0.389   0.199  -7.220  1.00  2.61           C  
ANISOU    9  CB  PHE A 397      359    314    321     28    -33     35       C  
ATOM     10  CG  PHE A 397      -0.019   0.329  -8.689  1.00  1.91           C  
ANISOU   10  CG  PHE A 397      255    220    250     33    -34     35       C  
ATOM     11  CD1 PHE A 397       1.007  -0.433  -9.232  1.00  2.26           C  
ANISOU   11  CD1 PHE A 397      298    261    300     38    -46     33       C  
ATOM     12  CD2 PHE A 397      -0.716   1.188  -9.529  1.00  2.88           C  
ANISOU   12  CD2 PHE A 397      369    343    383     33    -23     36       C  
ATOM     13  CE1 PHE A 397       1.341  -0.323 -10.576  1.00  3.51           C  
ANISOU   13  CE1 PHE A 397      445    419    468     40    -40     31       C  
ATOM     14  CE2 PHE A 397      -0.384   1.302 -10.871  1.00  1.41           C  
ANISOU   14  CE2 PHE A 397      178    152    203     34    -23     39       C  
ATOM     15  CZ  PHE A 397       0.644   0.545 -11.394  1.00  2.09           C  
ANISOU   15  CZ  PHE A 397      263    240    290     35    -28     36       C  
ATOM     16  N   ASN A 398       0.426   3.476  -7.450  1.00  1.47           N  
ANISOU   16  N   ASN A 398      192    162    205     34    -25      7       N  
ATOM     17  CA  ASN A 398       0.008   4.701  -8.123  1.00  1.49           C  
ANISOU   17  CA  ASN A 398      191    153    223     35    -18      5       C  
ATOM     18  C   ASN A 398       0.693   4.746  -9.476  1.00  2.21           C  
ANISOU   18  C   ASN A 398      280    236    324     29    -17     15       C  
ATOM     19  O   ASN A 398       1.919   4.611  -9.551  1.00  1.48           O  
ANISOU   19  O   ASN A 398      181    145    236     22    -19     10       O  
ATOM     20  CB  ASN A 398       0.414   5.951  -7.329  1.00  1.65           C  
ANISOU   20  CB  ASN A 398      213    164    250     35    -20    -13       C  
ATOM     21  CG  ASN A 398      -0.202   5.982  -5.954  1.00  5.08           C  
ANISOU   21  CG  ASN A 398      652    609    668     40    -18    -27       C  
ATOM     22  OD1 ASN A 398      -1.366   6.332  -5.796  1.00  4.56           O  
ANISOU   22  OD1 ASN A 398      584    547    603     48     -8    -34       O  
ATOM     23  ND2 ASN A 398       0.574   5.602  -4.949  1.00  3.09           N  
ANISOU   23  ND2 ASN A 398      407    366    399     37    -28    -35       N  
ATOM     24  N   GLY A 399      -0.085   4.964 -10.532  1.00  1.43           N  
ANISOU   24  N   GLY A 399      186    130    228     33    -15     27       N  
ATOM     25  CA  GLY A 399       0.488   5.079 -11.860  1.00  1.46           C  
ANISOU   25  CA  GLY A 399      196    128    232     24    -11     37       C  
ATOM     26  C   GLY A 399      -0.293   4.302 -12.896  1.00  1.76           C  
ANISOU   26  C   GLY A 399      237    171    260     30    -14     49       C  
ATOM     27  O   GLY A 399      -1.521   4.186 -12.794  1.00  2.34           O  
ANISOU   27  O   GLY A 399      309    246    335     42    -22     50       O  
ATOM     28  N   GLY A 400       0.384   3.774 -13.905  1.00  2.53           N  
ANISOU   28  N   GLY A 400      339    274    349     23     -8     53       N  
ATOM     29  CA  GLY A 400      -0.373   3.011 -14.876  1.00  2.93           C  
ANISOU   29  CA  GLY A 400      395    330    389     29    -15     60       C  
ATOM     30  C   GLY A 400       0.403   2.793 -16.164  1.00  2.66           C  
ANISOU   30  C   GLY A 400      371    300    339     19     -4     63       C  
ATOM     31  O   GLY A 400       1.634   2.755 -16.164  1.00  2.55           O  
ANISOU   31  O   GLY A 400      349    293    328      8     11     54       O  
ATOM     32  N   PHE A 401      -0.361   2.649 -17.246  1.00  1.85           N  
ANISOU   32  N   PHE A 401      286    197    221     24    -14     72       N  
ATOM     33  CA  PHE A 401       0.121   2.045 -18.485  1.00  1.76           C  
ANISOU   33  CA  PHE A 401      285    195    187     18     -5     70       C  
ATOM     34  C   PHE A 401      -0.370   2.886 -19.653  1.00  3.53           C  
ANISOU   34  C   PHE A 401      544    409    387     15    -12     89       C  
ATOM     35  O   PHE A 401      -1.577   3.105 -19.793  1.00  3.36           O  
ANISOU   35  O   PHE A 401      532    379    367     31    -39     96       O  
ATOM     36  CB  PHE A 401      -0.418   0.612 -18.605  1.00  2.39           C  
ANISOU   36  CB  PHE A 401      356    285    268     29    -19     59       C  
ATOM     37  CG  PHE A 401      -0.136  -0.251 -17.393  1.00  1.48           C  
ANISOU   37  CG  PHE A 401      218    172    173     33    -20     47       C  
ATOM     38  CD1 PHE A 401      -0.893  -0.136 -16.232  1.00  1.35           C  
ANISOU   38  CD1 PHE A 401      192    150    172     37    -29     51       C  
ATOM     39  CD2 PHE A 401       0.888  -1.188 -17.419  1.00  3.59           C  
ANISOU   39  CD2 PHE A 401      476    446    444     35    -13     30       C  
ATOM     40  CE1 PHE A 401      -0.614  -0.920 -15.112  1.00  2.37           C  
ANISOU   40  CE1 PHE A 401      311    278    312     38    -31     44       C  
ATOM     41  CE2 PHE A 401       1.165  -1.977 -16.308  1.00  4.15           C  
ANISOU   41  CE2 PHE A 401      534    512    530     41    -22     23       C  
ATOM     42  CZ  PHE A 401       0.416  -1.846 -15.156  1.00  3.96           C  
ANISOU   42  CZ  PHE A 401      510    481    514     41    -31     33       C  
ATOM     43  N   GLY A 402       0.553   3.358 -20.489  1.00  4.01           N  
ANISOU   43  N   GLY A 402      625    471    425     -5     11     95       N  
ATOM     44  CA  GLY A 402       0.184   4.109 -21.681  1.00  5.61           C  
ANISOU   44  CA  GLY A 402      874    662    594    -11      5    118       C  
ATOM     45  C   GLY A 402      -0.228   3.225 -22.846  1.00  7.18           C  
ANISOU   45  C   GLY A 402     1088    877    762     -4     -5    113       C  
ATOM     46  O   GLY A 402       0.070   2.026 -22.860  1.00  7.43           O  
ANISOU   46  O   GLY A 402     1099    929    796      0      2     91       O  
ATOM     47  OXT GLY A 402      -0.868   3.679 -23.810  1.00  7.33           O  
ANISOU   47  OXT GLY A 402     1129    892    766      1    -23    122       O  
TER      48      GLY A 402                                                      
ATOM     49  N   GLY B 396      -1.180  -8.465 -24.596  1.00  3.06           N  
ANISOU   49  N   GLY B 396      491    386    285     74    -96   -105       N  
ATOM     50  CA  GLY B 396      -0.276  -8.781 -23.503  1.00  3.34           C  
ANISOU   50  CA  GLY B 396      506    410    351     80    -84   -107       C  
ATOM     51  C   GLY B 396      -0.944  -8.687 -22.144  1.00  2.66           C  
ANISOU   51  C   GLY B 396      409    305    296     72    -98    -80       C  
ATOM     52  O   GLY B 396      -2.166  -8.709 -22.040  1.00  3.46           O  
ANISOU   52  O   GLY B 396      513    399    403     61   -116    -68       O  
ATOM     53  N   PHE B 397      -0.122  -8.580 -21.103  1.00  2.34           N  
ANISOU   53  N   PHE B 397      356    259    274     77    -87    -74       N  
ATOM     54  CA  PHE B 397      -0.568  -8.490 -19.720  1.00  2.13           C  
ANISOU   54  CA  PHE B 397      324    217    270     68    -95    -50       C  
ATOM     55  C   PHE B 397      -0.072  -7.170 -19.148  1.00  3.57           C  
ANISOU   55  C   PHE B 397      493    414    448     66    -75    -33       C  
ATOM     56  O   PHE B 397       1.133  -6.893 -19.185  1.00  3.19           O  
ANISOU   56  O   PHE B 397      435    377    400     74    -60    -45       O  
ATOM     57  CB  PHE B 397       0.017  -9.652 -18.895  1.00  3.10           C  
ANISOU   57  CB  PHE B 397      450    313    415     79   -110    -59       C  
ATOM     58  CG  PHE B 397      -0.375  -9.624 -17.436  1.00  2.60           C  
ANISOU   58  CG  PHE B 397      390    233    364     68   -116    -33       C  
ATOM     59  CD1 PHE B 397       0.298  -8.820 -16.535  1.00  3.97           C  
ANISOU   59  CD1 PHE B 397      554    416    539     72   -107    -21       C  
ATOM     60  CD2 PHE B 397      -1.437 -10.388 -16.978  1.00  2.62           C  
ANISOU   60  CD2 PHE B 397      408    213    376     49   -130    -21       C  
ATOM     61  CE1 PHE B 397      -0.069  -8.789 -15.194  1.00  2.47           C  
ANISOU   61  CE1 PHE B 397      372    213    352     61   -111      1       C  
ATOM     62  CE2 PHE B 397      -1.803 -10.365 -15.642  1.00  4.13           C  
ANISOU   62  CE2 PHE B 397      606    392    570     34   -130      3       C  
ATOM     63  CZ  PHE B 397      -1.127  -9.560 -14.753  1.00  3.90           C  
ANISOU   63  CZ  PHE B 397      571    374    537     41   -120     14       C  
ATOM     64  N   ASN B 398      -0.998  -6.361 -18.626  1.00  1.78           N  
ANISOU   64  N   ASN B 398      264    189    222     54    -75    -10       N  
ATOM     65  CA  ASN B 398      -0.682  -5.168 -17.841  1.00  1.61           C  
ANISOU   65  CA  ASN B 398      235    176    203     51    -61      5       C  
ATOM     66  C   ASN B 398      -1.294  -5.354 -16.460  1.00  2.39           C  
ANISOU   66  C   ASN B 398      330    262    315     44    -68     19       C  
ATOM     67  O   ASN B 398      -2.512  -5.514 -16.339  1.00  2.32           O  
ANISOU   67  O   ASN B 398      321    251    311     33    -75     25       O  
ATOM     68  CB  ASN B 398      -1.279  -3.911 -18.477  1.00  2.04           C  
ANISOU   68  CB  ASN B 398      292    240    242     46    -56     18       C  
ATOM     69  CG  ASN B 398      -0.631  -3.554 -19.788  1.00  5.17           C  
ANISOU   69  CG  ASN B 398      701    649    615     46    -44     11       C  
ATOM     70  OD1 ASN B 398       0.573  -3.743 -19.979  1.00  4.54           O  
ANISOU   70  OD1 ASN B 398      616    577    532     48    -27     -3       O  
ATOM     71  ND2 ASN B 398      -1.433  -3.033 -20.714  1.00  4.75           N  
ANISOU   71  ND2 ASN B 398      664    598    542     45    -53     19       N  
ATOM     72  N   GLY B 399      -0.464  -5.341 -15.427  1.00  2.00           N  
ANISOU   72  N   GLY B 399      279    209    273     48    -66     20       N  
ATOM     73  CA  GLY B 399      -0.978  -5.512 -14.088  1.00  1.58           C  
ANISOU   73  CA  GLY B 399      231    146    223     39    -70     34       C  
ATOM     74  C   GLY B 399      -0.304  -4.606 -13.086  1.00  1.50           C  
ANISOU   74  C   GLY B 399      216    143    212     42    -64     38       C  
ATOM     75  O   GLY B 399       0.929  -4.518 -13.064  1.00  2.80           O  
ANISOU   75  O   GLY B 399      374    309    381     54    -66     27       O  
ATOM     76  N   GLY B 400      -1.102  -3.924 -12.266  1.00  1.33           N  
ANISOU   76  N   GLY B 400      193    126    187     31    -55     48       N  
ATOM     77  CA  GLY B 400      -0.573  -3.108 -11.192  1.00  1.64           C  
ANISOU   77  CA  GLY B 400      231    170    223     33    -51     49       C  
ATOM     78  C   GLY B 400      -1.127  -3.568  -9.864  1.00  1.82           C  
ANISOU   78  C   GLY B 400      269    187    233     22    -52     59       C  
ATOM     79  O   GLY B 400      -2.340  -3.757  -9.731  1.00  3.26           O  
ANISOU   79  O   GLY B 400      452    373    414      7    -41     64       O  
ATOM     80  N   PHE B 401      -0.253  -3.766  -8.877  1.00  1.52           N  
ANISOU   80  N   PHE B 401      246    144    187     28    -65     59       N  
ATOM     81  CA  PHE B 401      -0.623  -4.410  -7.623  1.00  3.07           C  
ANISOU   81  CA  PHE B 401      471    333    364     16    -69     73       C  
ATOM     82  C   PHE B 401      -0.128  -3.557  -6.463  1.00  2.70           C  
ANISOU   82  C   PHE B 401      430    295    302     20    -70     69       C  
ATOM     83  O   PHE B 401       1.065  -3.240  -6.389  1.00  3.12           O  
ANISOU   83  O   PHE B 401      476    348    361     38    -89     57       O  
ATOM     84  CB  PHE B 401       0.000  -5.811  -7.548  1.00  3.10           C  
ANISOU   84  CB  PHE B 401      491    319    369     22    -87     72       C  
ATOM     85  CG  PHE B 401      -0.367  -6.700  -8.708  1.00  3.28           C  
ANISOU   85  CG  PHE B 401      509    332    406     20    -88     70       C  
ATOM     86  CD1 PHE B 401       0.308  -6.616  -9.923  1.00  2.31           C  
ANISOU   86  CD1 PHE B 401      365    212    300     36    -92     53       C  
ATOM     87  CD2 PHE B 401      -1.398  -7.618  -8.582  1.00  2.94           C  
ANISOU   87  CD2 PHE B 401      484    274    358     -2    -85     83       C  
ATOM     88  CE1 PHE B 401      -0.043  -7.439 -10.993  1.00  3.35           C  
ANISOU   88  CE1 PHE B 401      498    334    441     36    -96     48       C  
ATOM     89  CE2 PHE B 401      -1.753  -8.443  -9.651  1.00  3.92           C  
ANISOU   89  CE2 PHE B 401      607    386    497     -5    -91     78       C  
ATOM     90  CZ  PHE B 401      -1.074  -8.351 -10.851  1.00  3.43           C  
ANISOU   90  CZ  PHE B 401      526    327    449     17    -99     60       C  
ATOM     91  N   GLY B 402      -1.035  -3.192  -5.558  1.00  2.15           N  
ANISOU   91  N   GLY B 402      370    236    212      3    -50     73       N  
ATOM     92  CA  GLY B 402      -0.667  -2.457  -4.360  1.00  3.70           C  
ANISOU   92  CA  GLY B 402      577    442    387      5    -52     67       C  
ATOM     93  C   GLY B 402       0.313  -3.200  -3.466  1.00  7.12           C  
ANISOU   93  C   GLY B 402     1046    861    798     14    -85     75       C  
ATOM     94  O   GLY B 402       0.347  -4.438  -3.475  1.00  7.89           O  
ANISOU   94  O   GLY B 402     1156    943    898     10    -93     84       O  
ATOM     95  OXT GLY B 402       1.087  -2.585  -2.711  1.00  6.97           O  
ANISOU   95  OXT GLY B 402     1032    848    769     25   -101     63       O  
TER      96      GLY B 402                                                      
HETATM   97  O   HOH A 501      -1.927   8.017  -3.768  1.00  5.44           O  
ANISOU   97  O   HOH A 501      702    661    706     60      1    -85       O  
HETATM   98  O   HOH A 502       0.294   4.099 -26.286  1.00 11.35           O  
ANISOU   98  O   HOH A 502     1698   1418   1198    -37     16    134       O  
HETATM   99  O   HOH A 503      -0.928  -0.394   0.648  1.00  9.90           O  
ANISOU   99  O   HOH A 503     1444   1277   1040    -16    -30     36       O  
HETATM  100  O   HOH B 501       2.587  -2.907  -0.541  1.00  8.11           O  
ANISOU  100  O   HOH B 501     1214    988    880     39   -146     54       O  
HETATM  101  O   HOH B 502       0.772  -6.014  -1.288  1.00  6.37           O  
ANISOU  101  O   HOH B 502     1031    728    660      1   -119    102       O  
HETATM  102  O   HOH B 503      -1.869  -5.857  -4.277  1.00  8.07           O  
ANISOU  102  O   HOH B 503     1187    956    925    -34    -54    108       O  
HETATM  103  O   HOH B 504      -2.422 -11.022 -24.672  1.00  4.69           O  
ANISOU  103  O   HOH B 504      705    547    529     75   -153   -145       O  
HETATM  104  O   HOH B 505       3.145  -5.510   0.125  1.00  7.26           O  
ANISOU  104  O   HOH B 505     1155    838    764     43   -181     78       O  
MASTER      203    0    0    0    0    0    0    6  102    2    0    2          
END                                                                             
